These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1356426)

  • 1. Platelet monoamine oxidase in schizophrenia: a meta-analysis.
    Marcolin MA; Davis JM
    Schizophr Res; 1992 Sep; 7(3):249-67. PubMed ID: 1356426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet monoamine-oxidase activity in schizophrenia. Relation to genetic load of the illness and treatment with antipsychotic drugs.
    Kemali D; Maj M; Ariano MG; Salvati A
    Encephale; 1985; 11(1):31-4. PubMed ID: 2859981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of neuroleptic drugs on platelet monoamine oxidase in psychiatric patients.
    Meltzer HY; Duncavage MB; Jackman H; Arora RC; Tricou BJ; Young M
    Am J Psychiatry; 1982 Oct; 139(10):1242-8. PubMed ID: 6127035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human platelet MAO in drug-free and medicated schizophrenic patients.
    Friedhoff AJ; Miller JC; Weisenfreund J
    Am J Psychiatry; 1978 Aug; 135(8):952-5. PubMed ID: 27104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schizophrenia and platelet monoamine oxidase: research strategies.
    Buchsbaum MS; Coursey RD; Murphy DL
    Schizophr Bull; 1980; 6(2):375-84. PubMed ID: 6103578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of neuroleptics on platelet monoamine oxidase activity.
    Ho BT; Smith RC; Kralik P; Allen R; Schoolar J; Khan M; DeJohn C
    Biol Psychiatry; 1982 Aug; 17(8):885-95. PubMed ID: 6126230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Schizophrenic outcome in late life: symptom state and platelet monoamine oxidase activity.
    Bridge TP; Jeste DV; Wise CD; Potkin SG; Phelps BH; Wyatt RJ
    Psychiatry Res; 1984 Feb; 11(2):91-7. PubMed ID: 6143337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptic drug effect on platelet monoamine oxidase and plasma amine oxidase in schizophrenia.
    Baron M; Gruen R; Levitt M; Kane J
    Psychiatry Res; 1982 Oct; 7(2):179-87. PubMed ID: 6128754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low platelet MAO activity in chronic schizophrenics: a long-term effect of neuroleptic treatment?
    Del Vecchio M; Maj M; D'Ambrosio A; Kemali D
    Psychopharmacology (Berl); 1983; 79(2-3):177-9. PubMed ID: 6133302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet monoamine oxidase activity in schizophrenia. Relationship to disease, treatment, institutionalization and outcome.
    Mann J; Thomas KM
    Br J Psychiatry; 1979 Apr; 134():366-71. PubMed ID: 36192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A probable neuroleptic effect on platelet monoamine oxidase in chronic schizophrenic patients.
    DeLisi LE; Wise CD; Bridge TP; Rosenblatt JE; Wagner RL; Morihisa J; Karson C; Potkin SG; Wyatt RJ
    Psychiatry Res; 1981 Feb; 4(1):95-107. PubMed ID: 6111821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of blood platelet monoamine oxidase activity in schizophrenic patients on phenothiazines.
    Takahashi S; Yamane H; Tani N
    Folia Psychiatr Neurol Jpn; 1975; 29(3):207-14. PubMed ID: 2524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet MAO concentration and molecular activity: II. Comparison of normal and schizophrenic populations.
    Rose RM; Castellani S; Boeringa JA; Malek-Ahmadi P; Lankford DA; Bessman JD; Fritz RR; Denney CB; Denney RM; Abell CW
    Psychiatry Res; 1986 Feb; 17(2):141-51. PubMed ID: 2870529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet monoamine oxidase activity in schizophrenic patients.
    Becker RE; Shaskan EG
    Am J Psychiatry; 1977 May; 134(5):512-7. PubMed ID: 848577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet MAO in schizophrenics: relationship to symptomatology and neuroleptics.
    Paik IH; Lee C; Kim CE
    Biol Psychiatry; 1988 Jan; 23(1):93-5. PubMed ID: 2892539
    [No Abstract]   [Full Text] [Related]  

  • 16. Poor outcome and low platelet MAO activity in chronic schizophrenia.
    Bierer L; Docherty JP; Young JG; Giller E; Cohen D
    Am J Psychiatry; 1984 Feb; 141(2):257-60. PubMed ID: 6140867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood platelet monoamine oxidase activity in anergic schizophrenics.
    Shaskan EG; Becker RE
    Natl Inst Drug Abuse Res Monogr Ser; 1975 Nov; (3):29-35. PubMed ID: 1233383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet glutathione peroxidase and monoamine oxidase activity in schizophrenics with CT scan abnormalities: relation to psychosocial variables.
    Buckman TD; Kling A; Sutphin MS; Steinberg A; Eiduson S
    Psychiatry Res; 1990 Jan; 31(1):1-14. PubMed ID: 1969170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MAO inhibitory side effects of neuroleptics and platelet serotonin content in schizophrenic patients.
    Mészáros Z; Borcsiczky D; Máté M; Tarcali J; Tekes K; Magyar K
    J Neural Transm Suppl; 1998; 52():79-85. PubMed ID: 9564610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with decreased platelet MAO activity in chronic schizophrenics.
    Maj M; Arena F; Galderisi S; Starace F; Kemali D
    Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(1):79-86. PubMed ID: 2885896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.